This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk

Prescribing and adverse event reporting information found at the bottom of the page.

Contact Us

Prescribing Information

BEVESPI® glycopyrronium/formoterol fumarate dihydrate) Prescribing Information
FULVESTRANT Prescribing Information
FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal) Prescribing Information
FORXIGA® (dapagliflozin) Prescribing Information

IMFINZI® (durvalumab) Prescribing Information

IMJUDO®▼(tremelimumab) Prescribing Information

LOKELMA® (sodium zirconium cyclosilicate) Prescribing Information

LYNPARZA® (olaparib) Prescribing Information

SYMBICORT®(budesonide/formoterol) Asthma Prescribing Information
SYMBICORT®(budesonide/formoterol) COPD Prescribing Information
TAGRISSO®(osimertinib) Prescribing Information
TEZSPIRE®▼(tezepelumab) Prescribing Information
TRIXEO®(formoterol fumarate dihydrate/ glycopyrronium/budesonide) Prescribing Information
TRUQAP®▼ (capivasertib) Prescribing Information
WAINZUA®▼ (eplontersen) Prescribing Information
ZOLADEX®(goserelin) Prescribing Information

GB-76702 | June 2026

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling ‌‌‌0‌‌‌8‌‌‌‌‌0‌‌‌‌0‌‌‌ ‌‌7‌‌‌‌‌‌8‌‌‌3‌‌‌ ‌‌0‌‌‌‌‌0‌‌‌‌3‌‌‌‌3‌‌‌.

This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Cookie Policy

Contact Us

Thank you. We will be in touch

Prescribing Information